Correlation between Anthrax Lethal Toxin Neutralizing Antibody Levels and Survival in Guinea Pigs and Nonhuman Primates Vaccinated with the AV7909 Anthrax Vaccine Candidate

The anthrax vaccine candidate AV7909 is being developed as a next generation vaccine for a post-exposure prophylaxis (PEP) indication against anthrax. AV7909 consists of the Anthrax Vaccine Adsorbed (AVA, BioThrax(®)) bulk drug substance adjuvanted with the immunostimulatory oligodeoxynucleotide (OD...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Vaccine
Autors principals: Savransky, Vladimir, Shearer, Jeffry D., Gainey, Melicia R., Sanford, Daniel C., Sivko, Gloria S., Stark, Gregory V., Li, Na, Ionin, Boris, Lacy, Michael J., Skiadopoulos, Mario H.
Format: Artigo
Idioma:Inglês
Publicat: 2017
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5580334/
https://ncbi.nlm.nih.gov/pubmed/28774566
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2017.07.076
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars